Search Results 101-110 of 16728 for GLP-1 agonists
GLP-1 Agonists for Weight Loss: Do They Increase Complications in Non-diabetic Patients Undergoing Primary Total Hip Arthroplasty? J Arthroplasty. 2025 Aug ...
Mishra S, Persons PA, Bersoux S. Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period? Cleve Clin J Med. 2025 Apr 1; 92 ( ...
Central alpha agonists. Central agonists. Examples of central-acting agents. Several central-acting agents are available. The best one for you depends on ...
... GLP-1 receptor agonists and thiazolidinediones) prior to Screening. NOTE: Sulfonylureas and insulin are only permitted if glycemia is self-monitored by the ...
Subjects in the non-pancreatic disease subgroup (i.e., T2DM) on longer acting agents, including thiazolidinediones and once-weekly GLP-1 agonists (Bydureon ...
GLP-1 Agonists for Weight Loss: Do They Increase Complications in Non-diabetic Patients Undergoing Primary Total Hip Arthroplasty? J Arthroplasty. 2025 Mar ...
The purpose of this study is to identify twin pairs where one or both the siblings have Irritable bowel syndrome (IBS) based on the Rome III criteria and to ...
GLP-1 agonists: a game changer in pain treatment and addiction. Pain Manag. 2025 Jul 28; 1-13 Epub 2025 July 28. View PubMed; Encalada S, Gupta S, Hunt C ...
... Glucagon-Like Peptide-1 Receptor Agonists and Bariatric Surgery. Arthroplast Today. 2026 Apr; 38:101988 Epub 2026 Mar 10. View PubMed; Fehring TK, Otero JE ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness ... Receipt of glucagon-like peptide-1 agonists. Adults lacking the capacity to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.